Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospitalArtículo Original Published on 2023-03-282024-09-05 Journal: Revista peruana de medicina experimental y salud pública [Category] update2024, [키워드] Azithromycin Azitromicina COVID-19 Farmacovigilancia Hidroxicloroquina Hydroxychloroquine Ivermectin Ivermectina pharmacovigilance Tocilizumab [DOI] 10.17843/rpmesp.2023.401.11563 PMC 바로가기 [Article Type] Artículo Original
Familiar Dermatologic Drugs as Therapies for COVID-19Review Published on 2021-02-012023-07-06 Journal: Actas Dermosifiliogr (Engl Ed) [Category] SARS, [키워드] Antimalarials Antipalúdico chloroquine. cloroquina coronavirus Hidroxicloroquina Hydroxychloroquine Ivermectin Ivermectina melatonin Melatonina Severe acute respiratory syndrome Síndrome respiratorio agudo severo [DOI] 10.1016/j.ad.2020.09.004 PMC 바로가기 [Article Type] Review
Guidelines for clinical management of SARS-CoV-2 infectionArticle Published on 2020-01-012023-07-05 Journal: Gaceta médica de México [Category] SARS, [키워드] COVID-19 Favipiravir Immunoglobulin G Inmunoglobulina G Ivermectin Ivermectina Neumonía Nitazoxanida nitazoxanide Pneumonia SARS-CoV-2 Tocilizumab [DOI] 10.24875/GMM.M21000461